Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2014-04-07 13:07:48

The Effects of Aspirin in Gestation and Reproduction (EAGeR) medical trial has found that, in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss. However, in women with one pregnancy loss within the previous 12 months, there did appear to be a benefit. Jean Wactawski-Wende, PhD, professor in the Department of Epidemiology and Environmental Health in the School of Public Health and Health Professions at the University at Buffalo,...

2014-04-07 04:20:23

DUBLIN, April 4, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/zlj658/global_and ) has announced the addition of the "Global and Chinese Salicylic Acid (SA) Industry Report 2014" [http://www.researchandmarkets.com/research/zlj658/global_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The Global and Chinese Salicylic Acid (SA) Industry Report 2014 is a professional and in-depth...

2014-04-03 12:28:34

MUMBAI, India, April 3, 2014 /PRNewswire/ -- - GRC 27864 is a potent, selective, orally bioavailable inhibitor of mPGES-1 - The molecule has successfully completed pre-clinical and Phase 1 enabling studies. Regulatory submission has been filed for Phase 1 trial (first-in-human) with MHRA, UK - mPGES-1 inhibitors selectively block the production of PGE2 while sparing other prostanoids of physiological importance...

2014-03-13 08:28:09

PITTSBURGH, March 13, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that the United States District Court for the Eastern District of Virginia has ruled invalid a patent, United States Patent No. RE44,048, related to Pfizer's Celebrex® (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules. Mylan was sued by G.D. Searle LLC and Pfizer Asia Pacific PTE, Ltd. for alleged infringement of this patent in connection with Mylan's Abbreviated New Drug Application (ANDA) for...

2014-03-12 20:24:16

DUBLIN, March 12, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States District Court for the Eastern District of Virginia has ruled that United States Patent No. RE44,048 (the '048 Patent) is invalid. Actavis was earlier sued by Plaintiffs G.D. Searle LLC and Pfizer Asia Pacific PTE, Ltd. for infringement of the '048 Patent in connection with its Abbreviated New Drug Application directed to Actavis' generic version of Pfizer's Celebrex® (celecoxib)...

2014-03-07 16:22:47

NASHVILLE, Tenn., March 7, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that data from a recent study evaluating the efficacy and safety of Caldolor(®) (ibuprofen) Injection will be presented at the Pediatric Anesthesiology 2014 conference in Fort Lauderdale, Florida. The pediatric study met its primary endpoint demonstrating that Caldolor was associated with a statistically significant reduction in temperature within the first 2 hours of...

2014-03-05 16:26:21

NEWARK, Calif., March 05, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the 26th Annual ROTH Conference on Monday, March 10, 2014, at the Ritz Carlton in Dana Point, California. Depomed management is scheduled to present at 1:00 p.m. PT on Monday, March 10, with one-on-one meetings held throughout the day. A webcast of the presentation can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A...

2014-03-04 23:26:00

DeepResearchReports.com adds “2014 Deep Research Report on Global and China Salicylic Acid (SA) Industry” and “2014 Deep Research Report on Global and China Hyaluronic Acid Solution Industry” reports to its research database. Dallas, Texas (PRWEB) March 04, 2014 "2014 Deep Research Report on Global and China Hyaluronic Acid Solution Industry” is a professional and in-depth research report on China and Global Hyaluronic Acid Solution market. The report introduces Hyaluronic...

2014-02-21 08:22:21

DUBLIN, Feb. 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/q27vfh/ophthalmic_drugs ) has announced the addition of the "Ophthalmic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Globally, the ophthalmic drugs market is witnessing significant growth due to increasing prevalence of eye disorders such as diabetic...

2014-02-20 16:24:56

NEWARK, Calif., Feb. 20, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the 2014 RBC Capital Markets' Healthcare Conference at The New York Palace Hotel in New York City. The presentation at the RBC conference is scheduled for 2:05 pm EST (11:05 am PST) on Wednesday, February 26, 2014. Depomed will also be presenting at the Cowen 34(th) Annual Healthcare Conference at the Boston Marriott Copley Place Hotel in Boston at 8:40 am EST...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related